Lung Fung Group Holdings Limited (HKG:2290)

Lung Fung Group Holdings Cash Flow Statement

Financials in millions HKD. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023
Net Income	170.43	144.54	-27.14
Depreciation & Amortization	174.34	134.2	128.1
Loss (Gain) From Sale of Assets	0.08	0.15	0.07
Asset Writedown & Restructuring Costs	53.48	16.6	17.69
Other Operating Activities	56.19	66.82	14.86
Change in Accounts Receivable	7.32	-16.98	11.34
Change in Inventory	-110.64	-49.37	-67.78
Change in Accounts Payable	1,110	937.72	637.44
Change in Other Net Operating Assets	1.02	0.26	1.61
Operating Cash Flow	1,462	1,234	716.18
Operating Cash Flow Growth	18.52%	72.29%	-
Capital Expenditures	-54.87	-26	-10.76
Sale (Purchase) of Real Estate	-	-1.42	-
Other Investing Activities	-38.68	-62.37	-7.09
Investing Cash Flow	-93.55	-89.79	-17.85
Short-Term Debt Issued	319.36	399.27	481.68
Total Debt Issued	319.36	399.27	481.68
Short-Term Debt Repaid	-1,476	-1,339	-999.05
Long-Term Debt Repaid	-146.57	-119.65	-86.89
Total Debt Repaid	-1,623	-1,459	-1,086
Net Debt Issued (Repaid)	-1,303	-1,060	-604.27
Other Financing Activities	-47.14	-46.28	-27.46
Financing Cash Flow	-1,350	-1,106	-631.73
Foreign Exchange Rate Adjustments	-0.01	-0.01	-0.08
Net Cash Flow	18.42	38.26	66.51
Free Cash Flow	1,408	1,208	705.42
Free Cash Flow Growth	16.53%	71.23%	-
Free Cash Flow Margin	57.21%	59.78%	64.48%
Free Cash Flow Per Share	3.75	3.22	1.88
Cash Interest Paid	51.47	52.66	32.47
Cash Income Tax Paid	22.47	1.31	0.16
Levered Free Cash Flow	283.54	142.24	-
Unlevered Free Cash Flow	315.71	175.15	-
Change in Working Capital	1,008	871.62	582.6

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every year for this company.

Update frequency:

Yearly

Last checked:

Jul 10, 2026

Data Sources Report a data error